Overview of the EU CTA Regulatory Framework and Future Direction of the EU Clinical Trial Directive
Published on: Jan 5, 2010
Over the last few years, the European authorities have undertaken substantial new regulatory initiatives regarding the conduct of drug development activities, Clinical Trial Application (CTA) and Marketing Authorisation Application (MAA) submissions.
Download the full resource now
Fill in the form to download the content